Spots Global Cancer Trial Database for mfolfirinox
Every month we try and update this database with for mfolfirinox cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| Single-arm Study of Nimotuzumab Combined With mFOLFIRNIOX as Postoperative Adjuvant Therapy in Pancreatic Cancer | NCT06389760 | Pancreatic Canc... | Nimotuzumab mFOLFIRINOX | 18 Years - 70 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | NCT04228601 | Advanced Pancre... | Fluzoparib Fluzoparib plac... mFOLFIRINOX | 18 Years - | Jiangsu HengRui Medicine Co., Ltd. | |
| Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | NCT01526135 | Pancreatic Aden... | mFolfirinox Gemcitabine | 18 Years - 79 Years | UNICANCER | |
| mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma | NCT04986930 | Pancreatic Aden... Pancreatic Canc... | SBRT+mFOLFIRINO... mFOLFIRINOX | 19 Years - | Asan Medical Center | |
| Preoperative Radiotherapy And ASTX660 in Rectum Cancer | NCT05912075 | Locally-advance... | mFOLFIRINOX Pelvic radiothe... Capecitabine TOLINAPANT (AST... Pelvic radiothe... FOLFOX4 CAPOX | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma | NCT05968326 | Adenocarcinoma,... | Autogene cevume... Atezolizumab mFOLFIRINOX | 18 Years - | Genentech, Inc. | |
| Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma | NCT06069778 | Pancreatic Canc... | BNT321 Dose Lev... BNT321 Dose Lev... mFOLFIRINOX BNT321 RP2D | 18 Years - | BioNTech SE | |
| IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
| Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin | NCT05354817 | Colorectal Canc... | mFOLFIRINOX | 18 Years - 70 Years | Instituto do Cancer do Estado de São Paulo | |
| Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | NCT01526135 | Pancreatic Aden... | mFolfirinox Gemcitabine | 18 Years - 79 Years | UNICANCER | |
| IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting | NCT02967289 | Colon Cancer (H... | Irinotecan Folfox Protocol | 18 Years - 75 Years | UNICANCER | |
| Phase II Randomized Trial of mFOLFIRINOX +/- Ramucirumab in Advanced Pancreatic Cancer | NCT02581215 | Pancreatic Canc... | mFOLFIRINOX Ramucirumab Placebo | 18 Years - | Hoosier Cancer Research Network | |
| mFOLFIRINOX With or Without Stereotactic Body Radiotherapy in Locally Advanced Pancreatic Adenocarcinoma | NCT04986930 | Pancreatic Aden... Pancreatic Canc... | SBRT+mFOLFIRINO... mFOLFIRINOX | 19 Years - | Asan Medical Center | |
| Study of Proton Therapy in Adjuvant Pancreatic Cancer | NCT03885284 | Resected Pancre... | mFOLFIRINOX Proton beam rad... | 18 Years - | Georgetown University | |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | NCT04228601 | Advanced Pancre... | Fluzoparib Fluzoparib plac... mFOLFIRINOX | 18 Years - | Jiangsu HengRui Medicine Co., Ltd. | |
| A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected Pancreatic Ductal Adenocarcinoma | NCT05968326 | Adenocarcinoma,... | Autogene cevume... Atezolizumab mFOLFIRINOX | 18 Years - | Genentech, Inc. | |
| Intestinal Microbiota Impact for Prognosis and Treatment Outcomes in Early Luminal Breast Cancer and Pancreatic Cancer Patients | NCT05580887 | Breast Cancer Pancreas Cancer | mFOLFIRINOX Doxorubicin Cyclophosphamid Paclitaxel Carboplatin | 18 Years - 80 Years | Moscow Clinical Scientific Center | |
| A Study of OT-101 With mFOLFIRINOX in Patients With Advanced and Unresectable or Metastatic Pancreatic Cancer | NCT06079346 | Pancreatic Duct... | OT-101 mFOLFIRINOX | 18 Years - | Mateon Therapeutics | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| Preoperative Radiotherapy And ASTX660 in Rectum Cancer | NCT05912075 | Locally-advance... | mFOLFIRINOX Pelvic radiothe... Capecitabine TOLINAPANT (AST... Pelvic radiothe... FOLFOX4 CAPOX | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma | NCT05209074 | Pancreatic Duct... Resectable Panc... | Ivosidenib mFOLFIRINOX | 18 Years - 80 Years | Case Comprehensive Cancer Center | |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | NCT03991962 | Pancreatic Canc... | mFOLFIRINOX Stereotactic bo... | 18 Years - | Yale University | |
| Neoadjuvant Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma | NCT05825066 | Pancreas Adenoc... Borderline Rese... Locally Advance... | Nab paclitaxel Gemcitabine Radiological As... mFOLFIRINOX | 18 Years - | Wake Forest University Health Sciences | |
| Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy. | NCT04835064 | Pancreatic Aden... | Nab paclitaxel Gemcitabine mFOLFIRINOX | 18 Years - 75 Years | Fudan University | |
| mFOLFIRINOX as First-Line Chemotherapy in Treating Chinese Patients With Metastatic Pancreatic Cancer | NCT02028806 | Metastatic Panc... | mFOLFIRINOX | 18 Years - 65 Years | Sun Yat-sen University | |
| A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer | NCT04228601 | Advanced Pancre... | Fluzoparib Fluzoparib plac... mFOLFIRINOX | 18 Years - | Jiangsu HengRui Medicine Co., Ltd. | |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | NCT02676349 | Pancreatic Carc... | mFolfirinox Chemoradiothera... surgery Adjuvant chemot... | 18 Years - 75 Years | Institut de Cancérologie de Lorraine | |
| Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease | NCT05174169 | Stage III Colon... | Signatera test mFOLFOX6 3-6 mo... CAPOX 3 month mFOLFIRINOX mFOLFOX6 6 mont... CAPOX 6 month | 18 Years - | NRG Oncology | |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | NCT05546411 | Pancreatic Canc... Resectable Panc... Borderline Rese... Pancreatic Aden... | mFOLFIRINOX 5-Fluorouracil ... Oxaliplatin Irinotecan Leucovorin NIS793 Chemoradiation Surgery | 18 Years - | Dana-Farber Cancer Institute | |
| Short-course Versus Long-course Pre-operative Chemotherapy With mFOLFIRINOX or PAXG (CASSANDRA TRIAL) | NCT04793932 | Pancreas Ductal... | PAXG mFOLFIRINOX short-course ch... long-course che... | 18 Years - 75 Years | Associazione Italiana per lo Studio del Pancreas | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer | NCT02405585 | Pancreatic Canc... Pancreatic Carc... | mFOLFIRINOX Algenpantucel-L... SBRT Gemcitabine | 18 Years - | Lumos Pharma | |
| Neoadjuvant mFolfirinox With or Without Preoperative Concomitant Chemoradiotherapy in Patients With Borderline Resectable Pancreatic Carcinoma (PANDAS-PRODIGE 44) | NCT02676349 | Pancreatic Carc... | mFolfirinox Chemoradiothera... surgery Adjuvant chemot... | 18 Years - 75 Years | Institut de Cancérologie de Lorraine | |
| Trial Comparing Adjuvant Chemotherapy With Gemcitabine Versus mFolfirinox to Treat Resected Pancreatic Adenocarcinoma | NCT01526135 | Pancreatic Aden... | mFolfirinox Gemcitabine | 18 Years - 79 Years | UNICANCER | |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | NCT05546411 | Pancreatic Canc... Resectable Panc... Borderline Rese... Pancreatic Aden... | mFOLFIRINOX 5-Fluorouracil ... Oxaliplatin Irinotecan Leucovorin NIS793 Chemoradiation Surgery | 18 Years - | Dana-Farber Cancer Institute | |
| Impact of FOLFIRINOX Chemotherapy in IV Stage Colorectal Cancer Patients Previously Exposed to Irinotecan, Fluoropyrimidine and Oxaliplatin | NCT05354817 | Colorectal Canc... | mFOLFIRINOX | 18 Years - 70 Years | Instituto do Cancer do Estado de São Paulo | |
| Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma | NCT03991962 | Pancreatic Canc... | mFOLFIRINOX Stereotactic bo... | 18 Years - | Yale University | |
| A Study of Zolbetuximab With Chemotherapy in Adults With Pancreatic Cancer | NCT06396091 | Claudin 18.2 (C... | zolbetuximab mFOLFIRINOX | 18 Years - | Astellas Pharma Inc |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
